HOW WE HELP
We partner with laboratories to deliver actionable, concise, and clinically relevant reports that are easy for physicians to use.
Genetic results are complex, technology is constantly evolving, and the information infrastructure is not designed for genetics. Advance and accelerate the role of genetic testing for better outcomes and more interconnected healthcare solutions with Translational Software’s cloud-based pharmacogenomics solutions.
Our Precision Health Nexus connects laboratories, healthcare organizations, software vendors, and even consumers via an integrated network of partners.
We deliver high-value pharmacogenomic data with easy-to-understand recommendations and guidance for therapeutic care.
Drawing on genetic insights, we help clinics, hospitals, and healthcare providers enhance patient outcomes and fill gaps in infrastructure to deliver advanced, comprehensive care.
Our portal delivers a powerful and convenient user interface for monitoring and managing tests and results.
Our proprietary and rigorously vetted knowledge base and standards-based API enable health systems, laboratories, and independent software vendors to incorporate PGx data seamlessly.
Our population tool is a fast, efficient solution for evaluating a cohort of patients to identify those who would benefit most from PGx testing.
"Translational Software understands pharmacogenomic testing better than anyone else in the field, and they were able to create a platform that seamlessly delivered on our vision."
Chief Medical Officer at 2bPrecise LLC
"Integrating Translational Software’s PGx knowledge base within our e-prescribing platform allows us to deliver an in-workflow, evidence-based approach to medication prescribing that can be used as part of routine care."
President of DrFirst
"Translational Software has taken the pioneering step of implementing the first pharmacogenomics solution that employs FHIR genomics for optimizing the prescription of patient medications, and has been a real leader in this arena."
Gil Alterovitz, Ph.D., a Harvard Medical School professor and co-chair of HL7’s Clinical Genomics Work Group